Intra-access flow (Qac), measured by ultrasound dilution, is a reliable method for screening for access dysfunction. Because of a reduced circulating volume and a relative decrease in blood pressure at the end of hemodialysis (HD), we hypothesized that Qac could be significantly reduced when measured late into HD. Fifty patients were prospectively evaluated for variation in Qac early and late into HD. There were 33 native fistulae and 17 synthetic grafts. Six separate measures of Qac were performed for each patient by ultrasound dilution (Transonic HD01 hemodialysis monitor; Transonic Systems, Inc., Ithaca, NY): three within the first 30 minutes and three within the last 30 minutes of HD. Session time was 3.5 or 4 hours, and mean net ultrafiltration was 3.3 ؎ 0.9 L/HD. Early and late into HD, mean arterial pressure (MAP) decreased from 100.0 ؎ 14.6 to 92.8 ؎ 17.8 mm Hg, heart rate from 73 ؎ 11 to 79 ؎ 15 bpm, and hematocrit increased from 34 ؎ 3 to 38 ؎ 4%. For the whole group, mean Qac decreased from 1,101.7 ؎ 566.7 to 972.5 ؎ 515.6 ml/min (p ‫؍‬ NS); when Qac was corrected for a MAP of 100 mm Hg, the reduction remained nonsignificant (from 1,101.7 to 1,048.0 ml/min). When considering native and synthetic fistulae separately, the drop in Qac was still nonsignificant (from 1,098.9 ؎ 613.4 to 983.2 ؎ 593.2 for native fistulae versus 1,107.2 ؎ 480.5 to 999.8 ؎ 379.8 ml/min for grafts, p ‫؍‬ NS). Overall, the percent reduction in Qac early versus late into HD was 11.7%, whereas it reached only 4.9% when access flows corrected for MAP were considered. We conclude that variation in Qac during HD is relatively small, especially when values are corrected for MAP. Therefore, according to our results, Qac measures by using the ultrasound dilution method made at any time during HD should be reliable for most patients. ASAIO Journal 2000; 46:452-455.
Prophylactic repair of vascular accesses at risk for failure before thrombosis, by either interventional radiology or surgery, has been shown to significantly prolong the lifetime of the access when compared with an attempted repair after a thrombotic event. 1, 2 Several recommendations for routine monitoring of permanent vascular accesses (native fistulae and synthetic grafts) to detect incipient failure have been proposed. 3 Access blood flow (Qac) measurement by using the ultrasound dilution technique described by Krivitsky is cer-tainly a reliable method of screening for access dysfunction. 4 A decrease in Qac has been shown to be a significant predictor of subsequent short-term thrombosis for both grafts and native fistulae. 5 Neyra et al. recently demonstrated that a 35% reduction in Qac was related to a 14 -fold increase in risk for thrombosis compared with access without change in Qac. 6 Because an abrupt or progressive decrease in Qac for a given patient should alert the clinician, serial measures over time, performed on a monthly basis, if possible, prove to be particularly useful.
On the other hand, important hemodynamic changes occur during hemodialysis (HD). Considering variations in blood volume and blood pressure during HD, Qac could be significantly altered by such variations, and one could argue that Qac measures should be performed at approximately the same time during HD for a given patient, especially if comparison between the obtained values is considered determinant. Therefore, our objective was to determine whether Qac varies significantly early and late during a regular HD session, and whether there is an optimal time to perform Qac measurement by using the ultrasound dilution method.
Methods

Patients and Hemodialysis
Fifty chronic hemodialysis patients, 32 men and 18 women with a mean age of 64 Ϯ 14 years, were prospectively evaluated for variation in Qac early and late into HD. There were 33 native fistulae and 17 synthetic grafts; for puncture, 15 or 16 gauge needles were used. The blood pump flow rate was kept between 350 and 450 ml/min in our patients. Session time was 3.5 or 4 hours. The mean net ultrafiltration achieved was 3.3 Ϯ 0.9 L/HD for the evaluated sessions.
Instrumentation and Procedure
The ultrasound dilution method was used to measure access blood flow and access blood recirculation with the HD01 Hemodialysis Monitor System (Transonic Systems, Inc., Ithaca, NY), as previously described. 4 The system consists of the HD01 monitor, matched flow/dilution sensors, and a laptop computer preloaded with dilution measurement software. This method allows the measurement of access blood recirculation and effectively separates it from cardiopulmonary recirculation. For access flow measurement, the dialysis blood lines have to be reversed, inducing recirculation. A bolus of normal saline is injected into the venous drip chamber; the venous sensor samples the initial concentration of the injected bolus, while the arterial sensor samples the concentration of the bolus after it is diluted in the vascular access. The ratio between flow in the blood line and flow in the access is then calculated as:
where Qb is the dialyzer blood flow and Kr is the recirculation coefficient. Kr is equal to the ratio of areas under the dilution curves generated by the arterial and venous sensors, respectively. For measurements of access flow, the blood pump flow rate was maintained at 300 to 350 ml/min.
Measurements
Six separate measures of Qac were performed for each patient by ultrasound dilution: three within the first 30 minutes of HD and three within the last 30 minutes of HD. Therefore, a total of 300 Qac measures were performed. Access blood recirculation was measured once for each patient early into HD. Blood pressure and heart rate were recorded within the first 30 minutes of HD as well as within the last 30 minutes of HD, concomitant with Qac measures. Samples for hematocrit were drawn before and after HD.
A simple equation was used to correct Qac for a mean arterial pressure of 100 mm Hg:
where Qac' is the corrected Qac and MAP is the actual mean arterial pressure at the time of measurement.
Cardiac output was not measured because the dialysis machines and blood lines used did not allow the injection of the required amount of saline (30 ml) in a bolus for such a measurement without stopping the blood pump.
Statistical Analysis
Results are expressed as mean Ϯ SD. The obtained results were compared by using paired or unpaired Student's t-test, where appropriate, with a p value Ͻ 0.05 considered significant. Table 1 shows the hemodynamic changes early and late into HD for the 50 patients. Overall, the percent reduction in Qac early versus late into HD was 11.7%, whereas it reached only 4.9% when access flows corrected for MAP (expressed as Qac') were considered. The results obtained for the 33 native fistulae and the 17 grafts are also presented in Table 2 . Variation in early versus late Qac for the 50 patients can be seen in Figure 1 . No significant difference was observed; however, the difference tended to increase at higher Qac. Note that each point corresponds to the mean of three consecutive measures for both early and late Qac. There was little variation between the three measurements made early into HD (respective mean values of 1,108.4 Ϯ 600.1, 1,104.4 Ϯ 636.1, and 1,092.2 Ϯ 514.7 ml/min) and late into HD (respective mean values of 982.8 Ϯ 558.9, 982.2 Ϯ 520.5, and 972.7 Ϯ 494.3 ml/min), confirming the reproducibility of the method.
Results
The correlation between the difference in Qac (early minus late into HD) and the difference in MAP (early minus late into HD), although weak, was significant (p Ͻ 0.001) (Figure 2) . As shown in Figure 3 , there was no significant correlation between the change in Qac and the change in hematocrit early minus late into HD (rϽ0.01 and p ϭ NS). Figure 4 separately presents the variations in Qac early and late into HD for the 17 synthetic grafts and the 33 native fistulae. There was no significant difference for changes in early versus late Qac between both types of accesses, with mean decreases of 101.8 Ϯ 239.2 and 107.5 Ϯ 290.3 ml/min (p ϭ not significant) for native fistulae and synthetic grafts, Where AP represents arterial blood pressure. Where QacЈ expresses the access flow corrected for a MAP of 100 mm Hg. respectively. Among the 50 patients, 45 had no access recirculation; their mean Qac was 1,178.1 Ϯ 547.6 ml/min. Only five patients presented access blood recirculation with a mean value of 17.2 Ϯ 10.9% and a mean Qac of 360.8 Ϯ 91.8 ml/min early into HD. The difference in Qac in both subgroups was significant (p Ͻ 0.01). Figure 5 expresses the difference in access flow as a function of the average of the early and late access flows into HD (Bland-Altman plot).
Discussion
Decreased intra-access flow in grafts or native fistulae is a reliable predictor of future access thrombosis; therefore, a method allowing such a measurement becomes extremely useful to monitor hemodialysis accesses on a regular basis. The ultrasound dilution technology is practical and can be performed easily in the dialysis unit. However, the best timing for its application relative to the hemodialysis session has not been really determined. We were concerned that measuring Qac late into HD could result in falsely low values because of relative decreases in arterial blood pressure, circulating blood volume, and cardiac output. Such hemodynamic changes may be especially important during relatively short sessions of Ͻ 4 hours and for patients having large interdialytic weight gains.
The present study shows that the variation in Qac early, measured within the first 30 minutes of HD, and late, measured during the last 30 minutes of HD, is relatively small and can be considered not significant for both native fistulae and synthetic grafts. Indeed, the relative reduction reached Ͻ 12% for the entire group. These results are in agreement with the study of Sands et al. who showed, by using two different methods, that Qac was relatively constant throughout a stable HD treatment, decreasing by 10 to 12%. 7 However, as shown in Figure 1 , the observed difference (in absolute value) tends to increase at higher access flows, and this last consideration may need to be kept in mind for accesses with very high Qac for which the reduction may seem greater if not calculated in percentage.
Despite a relatively modest decrease in mean arterial blood pressure, for a more accurate interpretation, we decided to correct Qac for the mean arterial pressure. Our results show that when correcting for a MAP of 100 mm Hg, a decrease in Qac of Ͻ 5%, on average, can be expected. Sands et al. reported a significant decrease in MAP at 3 and 4 hours into HD, but they found that Qac did not vary significantly with MAP and that there was only a small positive correlation between Qac and cardiac output. 7 Unfortunately, we were unable to measure cardiac output in our center with the available technology.
In a recent publication, Rehman et al. 8 measured serial Qac in 32 patients, within 30, 90, and 150 minutes from the start of the HD session; they found a strong correlation between Qac and MAP, especially after 90 min, because each 10% decrease in MAP resulted in an 8% reduction in Qac. They concluded that Qac measurement could be performed up to 2 to 2.5 hours from the start of HD. In a subset of patients with a reduction in MAP of more than 15%, they suggest postponing Qac measurements; however, Qac measurements late into HD were not performed. Our data may be considered complimentary to their findings, because we measured Qac within the first and the last 30 minutes of 3.5 to 4 hour HD sessions. Because the variation in Qac, in our hands, does not change significantly, even in patients with greater decreases in MAP during HD, we consider that measurements of access flow by using the ultrasound dilution method made at any time during HD should, therefore, be reliable in most patients.
